Elbit Imaging Ltd. (EMITF)
USD 1.2
(0.0%)
USD 1.2
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 63.79 Million ILS | -0.35% |
| 2022 | 64.01 Million ILS | -11.42% |
| 2021 | 72.26 Million ILS | -29.15% |
| 2020 | 102 Million ILS | -32.11% |
| 2019 | 150.25 Million ILS | -41.29% |
| 2018 | 255.92 Million ILS | -74.84% |
| 2017 | 1.01 Billion ILS | -55.01% |
| 2016 | 2.26 Billion ILS | -16.36% |
| 2015 | 2.7 Billion ILS | -26.16% |
| 2014 | 3.66 Billion ILS | -19.79% |
| 2013 | 4.56 Billion ILS | -35.66% |
| 2012 | 7.09 Billion ILS | -31.59% |
| 2011 | 10.37 Billion ILS | -3.1% |
| 2010 | 10.7 Billion ILS | 14.3% |
| 2009 | 9.36 Billion ILS | 7.73% |
| 2008 | 8.69 Billion ILS | 2.63% |
| 2007 | 8.46 Billion ILS | 37.91% |
| 2006 | 6.14 Billion ILS | 62.3% |
| 2005 | 3.78 Billion ILS | -16.45% |
| 2004 | 4.52 Billion ILS | -17.74% |
| 2003 | 5.5 Billion ILS | -5.97% |
| 2002 | 5.85 Billion ILS | 29.89% |
| 2001 | 4.5 Billion ILS | 31.62% |
| 2000 | 3.42 Billion ILS | 20.15% |
| 1999 | 2.85 Billion ILS | 9.07% |
| 1998 | 2.61 Billion ILS | 36.72% |
| 1997 | 1.91 Billion ILS | 10.27% |
| 1996 | 1.73 Billion ILS | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 71.55 Million ILS | 0.0% |
| 2024 Q1 | 71.55 Million ILS | 12.17% |
| 2023 Q3 | 63.79 Million ILS | -4.6% |
| 2023 Q2 | 66.86 Million ILS | 0.0% |
| 2023 FY | 63.79 Million ILS | -0.35% |
| 2023 Q1 | 66.86 Million ILS | 4.46% |
| 2023 Q4 | 63.79 Million ILS | 0.0% |
| 2022 Q1 | 60.14 Million ILS | -16.78% |
| 2022 Q3 | 64.01 Million ILS | 6.44% |
| 2022 Q2 | 60.14 Million ILS | 0.0% |
| 2022 Q4 | 64.01 Million ILS | 0.0% |
| 2022 FY | 64.01 Million ILS | -11.42% |
| 2021 Q3 | 72.26 Million ILS | -21.09% |
| 2021 Q4 | 72.26 Million ILS | 0.0% |
| 2021 Q2 | 91.57 Million ILS | 0.0% |
| 2021 FY | 72.26 Million ILS | -29.15% |
| 2021 Q1 | 91.57 Million ILS | -10.22% |
| 2020 Q4 | 102 Million ILS | 0.0% |
| 2020 Q1 | 112.21 Million ILS | -25.32% |
| 2020 Q2 | 112.21 Million ILS | 0.0% |
| 2020 Q3 | 102 Million ILS | -9.1% |
| 2020 FY | 102 Million ILS | -32.11% |
| 2019 Q1 | - ILS | -100.0% |
| 2019 FY | 150.25 Million ILS | -41.29% |
| 2019 Q3 | 164.04 Million ILS | 0.0% |
| 2019 Q4 | 150.25 Million ILS | -8.41% |
| 2018 Q4 | 255.92 Million ILS | 0.0% |
| 2018 Q1 | 625.24 Million ILS | -38.54% |
| 2018 Q3 | - ILS | -100.0% |
| 2018 Q2 | 625.24 Million ILS | 0.0% |
| 2018 FY | 255.92 Million ILS | -74.84% |
| 2017 Q4 | 1.01 Billion ILS | 0.0% |
| 2017 FY | 1.01 Billion ILS | -55.01% |
| 2017 Q1 | 1.77 Billion ILS | -21.61% |
| 2017 Q2 | 1.77 Billion ILS | 0.0% |
| 2017 Q3 | 1.01 Billion ILS | -42.6% |
| 2016 FY | 2.26 Billion ILS | -16.36% |
| 2016 Q4 | 2.26 Billion ILS | -13.09% |
| 2016 Q3 | 2.6 Billion ILS | -1.63% |
| 2016 Q2 | 2.64 Billion ILS | -2.39% |
| 2016 Q1 | 2.7 Billion ILS | 248.17% |
| 2015 Q1 | 3.33 Billion ILS | 219.71% |
| 2015 Q2 | 2.87 Billion ILS | -13.96% |
| 2015 Q3 | 2.83 Billion ILS | -1.18% |
| 2015 Q4 | 778.25 Million ILS | -72.59% |
| 2015 FY | 2.7 Billion ILS | -26.16% |
| 2014 Q2 | 4.05 Billion ILS | -11.22% |
| 2014 FY | 3.66 Billion ILS | -19.79% |
| 2014 Q4 | 1.04 Billion ILS | -73.5% |
| 2014 Q3 | 3.94 Billion ILS | -2.79% |
| 2014 Q1 | 4.56 Billion ILS | 0.04% |
| 2013 FY | 4.56 Billion ILS | -35.66% |
| 2013 Q4 | 4.56 Billion ILS | -5.69% |
| 2013 Q3 | 4.83 Billion ILS | -16.66% |
| 2013 Q2 | 5.8 Billion ILS | -7.83% |
| 2013 Q1 | 6.3 Billion ILS | -11.19% |
| 2012 Q1 | 10.09 Billion ILS | -2.63% |
| 2012 Q4 | 7.09 Billion ILS | -9.49% |
| 2012 Q2 | 8.44 Billion ILS | -16.4% |
| 2012 FY | 7.09 Billion ILS | -31.59% |
| 2012 Q3 | 7.83 Billion ILS | -7.15% |
| 2011 Q2 | 11.09 Billion ILS | -1.62% |
| 2011 Q1 | 11.27 Billion ILS | 5.39% |
| 2011 FY | 10.37 Billion ILS | -3.1% |
| 2011 Q4 | 10.37 Billion ILS | -4.0% |
| 2011 Q3 | 10.8 Billion ILS | -2.64% |
| 2010 FY | 10.7 Billion ILS | 14.3% |
| 2010 Q2 | 11.39 Billion ILS | 23.61% |
| 2010 Q3 | 11.46 Billion ILS | 0.61% |
| 2010 Q1 | 9.21 Billion ILS | -1.55% |
| 2010 Q4 | 10.7 Billion ILS | -6.65% |
| 2009 FY | 9.36 Billion ILS | 7.73% |
| 2009 Q3 | 9.28 Billion ILS | 0.61% |
| 2009 Q2 | 9.22 Billion ILS | -0.66% |
| 2009 Q1 | 9.29 Billion ILS | 6.88% |
| 2009 Q4 | 9.36 Billion ILS | 0.86% |
| 2008 FY | 8.69 Billion ILS | 2.63% |
| 2008 Q2 | 8.9 Billion ILS | -4.09% |
| 2008 Q1 | 9.28 Billion ILS | 9.62% |
| 2008 Q3 | 8.58 Billion ILS | -3.64% |
| 2008 Q4 | 8.69 Billion ILS | 1.3% |
| 2007 Q4 | 8.46 Billion ILS | 8.6% |
| 2007 Q3 | 7.79 Billion ILS | 8.35% |
| 2007 Q2 | 7.19 Billion ILS | 17.56% |
| 2007 Q1 | 6.12 Billion ILS | -0.3% |
| 2007 FY | 8.46 Billion ILS | 37.91% |
| 2006 Q3 | 4.89 Billion ILS | 12.52% |
| 2006 Q4 | 6.14 Billion ILS | 25.56% |
| 2006 Q1 | 4.46 Billion ILS | 18.09% |
| 2006 FY | 6.14 Billion ILS | 62.3% |
| 2006 Q2 | 4.34 Billion ILS | -2.71% |
| 2005 Q2 | 4.37 Billion ILS | -0.19% |
| 2005 Q3 | 3.89 Billion ILS | -11.11% |
| 2005 FY | 3.78 Billion ILS | -16.45% |
| 2005 Q4 | 3.78 Billion ILS | -2.79% |
| 2005 Q1 | 4.38 Billion ILS | -3.12% |
| 2004 Q2 | 5.7 Billion ILS | 0.0% |
| 2004 Q3 | 4.55 Billion ILS | -20.12% |
| 2004 FY | 4.52 Billion ILS | -17.74% |
| 2004 Q4 | 4.52 Billion ILS | -0.65% |
| 2003 Q3 | 5.29 Billion ILS | 0.54% |
| 2003 Q4 | 5.5 Billion ILS | 3.95% |
| 2003 Q1 | 5.79 Billion ILS | -0.98% |
| 2003 Q2 | 5.26 Billion ILS | -9.13% |
| 2003 FY | 5.5 Billion ILS | -5.97% |
| 2002 Q1 | 5.28 Billion ILS | 17.25% |
| 2002 FY | 5.85 Billion ILS | 29.89% |
| 2002 Q2 | 5.79 Billion ILS | 9.69% |
| 2002 Q4 | 5.85 Billion ILS | 0.08% |
| 2002 Q3 | 5.84 Billion ILS | 0.91% |
| 2001 Q1 | 3.92 Billion ILS | 14.57% |
| 2001 Q4 | 4.5 Billion ILS | 4.31% |
| 2001 FY | 4.5 Billion ILS | 31.62% |
| 2001 Q3 | 4.32 Billion ILS | 0.0% |
| 2000 FY | 3.42 Billion ILS | 20.15% |
| 2000 Q1 | 2.78 Billion ILS | -2.34% |
| 2000 Q4 | 3.42 Billion ILS | 4.99% |
| 2000 Q3 | 3.26 Billion ILS | 13.65% |
| 2000 Q2 | 2.86 Billion ILS | 3.11% |
| 1999 FY | 2.85 Billion ILS | 9.07% |
| 1999 Q4 | 2.85 Billion ILS | 0.0% |
| 1998 FY | 2.61 Billion ILS | 36.72% |
| 1998 Q4 | 2.61 Billion ILS | 0.0% |
| 1997 FY | 1.91 Billion ILS | 10.27% |
| 1997 Q4 | 1.91 Billion ILS | 0.0% |
| 1996 Q4 | 1.73 Billion ILS | 0.0% |
| 1996 FY | 1.73 Billion ILS | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AVITA Medical, Inc. | 144.33 Million USD | 55.806% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -20086.709% |
| Össur hf. | 1.39 Billion USD | 95.423% |
| QHSLab, Inc. | 1.68 Million USD | -3693.79% |
| Wellstar International, Inc. | 957.89 Thousand USD | -6559.415% |
| Össur hf. | 1.39 Billion USD | 95.423% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 4.75 Million USD | -1240.71% |
| Aurora Spine Corporation | 11.92 Million USD | -434.982% |
| BrainsWay Ltd. | 62.97 Million USD | -1.299% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 144.38 Thousand USD | -44079.572% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 42.095% |
| Vivos Inc. | 1.61 Million USD | -3861.807% |
| Kelyniam Global, Inc. | 1.63 Million USD | -3807.04% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -5188.01% |
| Zecotek Photonics Inc. | 2.57 Million USD | -2379.31% |
| Avitar, Inc. | 1.74 Million USD | -3549.679% |
| Nanomix Corporation | 982.05 Thousand USD | -6395.563% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 38.02% |
| Theraclion SA | 18.66 Million EUR | -241.789% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.76 Million USD | -3508.746% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -8423.71% |
| Lombard Medical, Inc. | 67.76 Million USD | 5.869% |
| ALR Technologies Inc. | 193.21 Thousand USD | -32914.693% |
| Stratec SE | 529.71 Million USD | 87.958% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -6328.512% |
| Heart Tronics, Inc. | 4.04 Million USD | -1475.476% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 98.377% |
| VMS Rehab Systems, Inc. | 4.45 USD | -1433483046.067% |
| NewCardio, Inc. | 2.85 Million USD | -2135.85% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -3722.049% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -8546.701% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -13895.388% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -116415.672% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -34914.821% |
| SANUWAVE Health, Inc. | 22.41 Million USD | -184.574% |
| IR-Med Inc. | 999 Thousand USD | -6285.385% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | -210.544% |
| Polarean Imaging plc | 10.86 Million USD | -486.992% |
| United American Healthcare Corporation | 10.37 Million USD | -514.606% |
| ECGI Holdings, Inc. | 5.2 Million USD | -1126.399% |
| Nu-Med Plus, Inc. | 2.21 Million USD | -2783.77% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -188661.319% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | -2882.614% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -7225.692% |
| Urologix, Inc. | 5.66 Million USD | -1025.64% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | -2729.352% |
| Nexeon MedSystems Inc. | 20.35 Million USD | -213.442% |
| SS Innovations International, Inc. | 25.47 Million USD | -150.362% |
| Qualis Innovations, Inc. | 2431.00 USD | -2623923.036% |
| Smith & Nephew plc | 9.97 Billion USD | 99.36% |
| NIOX Group Plc | 116.47 Million USD | 45.235% |
| Fuse Medical, Inc. | 16.25 Million USD | -292.332% |
| Broncus Holding Corporation | 195.75 Million USD | 67.413% |
| Brain Scientific Inc. | 11.74 Million USD | -443.188% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -5977.113% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -221894.084% |